Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Autologous Stem Cell Transplantation: later-stage trial registry

3 of 3 indexed Autologous Stem Cell Transplantation trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Autologous Stem Cell Transplantation: 3 US clinical trials tracked, 3 recruiting.

Autologous Stem Cell Transplantation is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Center for International Blood and Marrow Transplant Research, running 2 of these trials.

Enrollment posture brief

Registry condition autologous-stem-cell-transplantation

OPEN 3 | RECR 100% | LATE 1 | EARLY 0 | RANK #5209 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Autologous Stem Cell Tra (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Autologous Stem Cell Transplantation

Autologous Stem Cell Transplantation lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Autologous Stem Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Autologous Stem Cell Transplantation is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Autologous Stem Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Olanzapine Drug
1 trials

US sites by state

Facility locations filed on Autologous Stem Cell Transplantation trials. A trial with sites in several states counts in each.

Minnesota 2 trials
Wisconsin 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Autologous Stem Cell Transplantation page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autologous Stem Cell Transplantation condition card totals 3 registered trials; most-linked intervention Olanzapine; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.